Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial

The Lancet ◽  
2020 ◽  
Vol 396 (10257) ◽  
pp. 1079-1089 ◽  
Author(s):  
Hyo-Soo Kim ◽  
Jeehoon Kang ◽  
Doyeon Hwang ◽  
Jung-Kyu Han ◽  
Han-Mo Yang ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document